Plain-English translation of NCT04160507 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Duke University are trying to understand why African Americans have a much higher risk of kidney failure than other groups. This study collects blood samples from African American adults—both those with kidney disease and those without—to grow kidney-like cells in the lab. By studying these cells, scientists hope to discover why some people with certain genetic mutations develop kidney failure while others don't.
African Americans are four times more likely to develop end-stage kidney disease than Caucasian Americans, largely due to mutations in a gene called APOL1. However, not everyone with this mutation gets kidney disease, and researchers don't yet understand why. This study aims to fill that gap by creating artificial kidney cells from patients' blood so scientists can study the disease process at a cellular level.
You likely qualify if…
You likely don't qualify if…
Your participation would involve donating a blood sample at Duke University. This blood will be used to create kidney-like cells in the laboratory—a process called growing induced pluripotent stem cells from your blood cells. You would not need to undergo any procedures or take any medications; the study is purely observational and research-based.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
United States
Enrollment target
~200 participants
Started
December 2019
Primary completion
November 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Opeyemi Olabisi, MD/PHD
Duke University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.